June 3, 20160Comments

#1 Stock Picker – Last Twelve Months – June 2016

The latest rankings have been released and New Constructs' CEO David Trainer is June's #1 ranked stock picker over the last twelve months (LTM) per SumZero Rankings

by Kyle Guske II

June 3, 20160Comments

#4 Stock Picker – Value – June 2016

The latest rankings have been released and New Constructs' CEO David Trainer is June's #4 ranked "Value" stock picker per SumZero Rankings.

by Kyle Guske II

May 9, 20160Comments

“Questioning Perrigo’s Growth” – Barron’s

This past weekend, Barron’s magazine featured our research for the fifth time in 2016 and 21st time since 2014. This time, Barron’s featured our Danger Zone report on Perrigo...

by Kyle Guske II

May 9, 20160Comments

“Valeant Doesn’t Look Cheap” – Barron’s

Over the weekend, Barron’s magazine featured our research for the fourth time in 2016 and 20th time since 2014. This time, Barron’s featured our research on Valeant...

by Kyle Guske II

May 6, 20160Comments

#1 Stock Picker – Value – May 2016

The latest rankings have been released and New Constructs' CEO David Trainer is May's #1 ranked "Value" stock picker per SumZero Rankings

by Kyle Guske II

May 6, 20160Comments

#2 Stock Picker – Last Twelve Months – May 2016

The latest rankings have been released and New Constructs' CEO David Trainer is May's #2 ranked stock picker over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

April 5, 20160Comments

New Constructs #1 Stock Picker – April 2016

The latest rankings are out and New Constructs' CEO David Trainer is April's #1 ranked stock picker over the last twelve months (LTM) per SumZero Rankings.

by Kyle Guske II

March 17, 20160Comments

#1 Ranked Stock Picker By SumZero

We are proud to announce that New Constructs has been ranked the #1 LTM Analyst per SumZero Rankings.

by Kyle Guske II

March 17, 20160Comments

SumZero Features New Constructs Research

On Tuesday (3/15/16) SumZero prominently featured our research on Valeant Pharmaceuticals (VRX) as the stock dropped over 50% in one day

by Kyle Guske II

March 14, 20160Comments

“Zillow Is Risky And Vulnerable” – Barron’s

This past weekend, Barron’s magazine featured our research for the third time in 2016 and 19th time since 2014. This time, Barron’s featured research from our Danger Zone...

by Kyle Guske II

March 11, 20160Comments

Danger Zone Call Featured In SumZero Face Off

SumZero featured our analysis on the multitude of issues facing Valeant Pharmaceuticals (VRX).

by Kyle Guske II

February 15, 20160Comments

“LinkedIn Is Still Significantly Overvalued” – Barron’s

This past weekend, Barron’s magazine featured our research for the second time in 2016 and 18th time since 2014. This time, Barron’s featured research from our Danger Zone...

by Kyle Guske II

January 18, 20160Comments

“Qlik’s Waning Value” – Barron’s

This past weekend, Barron’s magazine featured our research for the first time in 2016 and 17th time since 2014. This time, Barron’s featured research from our recent Danger...

by Kyle Guske II

October 19, 20150Comments

“Proofpoint Needs Profits” – Barron’s

This past weekend, Barron’s magazine featured our research for the seventh time in 2015 and 16th time since 2014. This time, Barron’s featured research from our recent Danger...

by Kyle Guske II

September 27, 20150Comments